Premature Ventricular Complexes: Diagnose, Evaluation, and Management

Ahmad Handayani, Anggia Chairuddin Lubis


Premature ventricular complexes (PVCs) are arrhythmias due to abnormal impulse formation in the ventricles. The incidence is detected as much as 1% on standard electrocardiographic (ECG) examination. The aim of this literature review is to explain the diagnosis, evaluation, and management of PVC. The diagnosis of PVC is determined from the symptoms and evidence from the ECG recording. Symptoms may include a faster heartbeat sensation, chest discomfort, skipped beat, and intermittenly strong heartbeat. Evidence of PVC is established by regular ECG recordings or Holter. A 12-ECG can help determine the location of source. PVC evaluation includes determine the dangerousity, the next examination step, the treatment options, and whether ablation is needed. Managements include medical therapy and catheter ablation. Catheter ablation is performed where treatment is unsatisfactory or if the PVC causing life threathening arrhythmia or cardiomyopathy. PVC is considered dangerous if the underlying disease is found in the form of cardiac structural abnormalities, ischemic heart disease or other arrhythmic disorders, more than 2000 PVC is found in 24 hours, complex morphology, different morphology, increased with exercise, PVC with non-outflow tract form, with short coupling interval, and with a wider QRS duration The incidence of VVC that is considered to be able to induce cardiomyopathy is from 10-26%. PVC requires a structured and systematic diagnosis and evaluation step to determine the appropriate treatment.



Premature ventricular complexes, management of PVC, diagnosis of PVC

Full Text:



Wexler R K, Pleister A, Raman, SV. Palpitations: Evaluation in The Clinical Setting. Am Fam Physician. 2017:(96)784-9.

Temiz A, Gazi E, Altun B, Gungor O, Barutcu A, Bekler A, et al. Fragmented QRS is associated with frequency of premature ventricular contraction in patients without overt cardiac diseases. Anatolian J Cardiol. 2015;(15) :456-62.

Rolando AH, Felani MR Frequent Ventricular Extrasystoles. Cermin Dunia Kedokteran. 2018;(45):759-762.

Perez-SIlva A, Merino JL. Frequent ventricular extrasystoles: significance, prognosis and treatment. E-journal of Cardiology Practice. 2011(9)

Premature Ventricular Contractions. Cleveland Clinic. [Online] [Cited: 11 17, 2021.]

Conditions & Treatments: premature-ventricular-contractions-pvcs-and-premature. Frankel Cardiovascular Center University of Michigan. [Online] [Cited: 11 17, 2021.]

J, CLine. Implantable loop recorders vs. Holter monitors. Wolters Kluwer Health. 2017:(47)

Andarade JG, Bennett MT, Deyell MW, Hawkins N, Krahn AD, Macle L, et al. The Clinical Cardiac Electrophysiology Handbook. Minneapolis : Cardiotext Publishing, LLC, 2016. pp. 229-262.

Burns E dan Buttner R. Premature Ventricular Complex (PVC) . Life In The Fastlane. [Online] 6 2, 2021. [Cited: 11 17, 2021.]

GM, Marcus. Evaluation and Management of Premature Ventricular Complexes. 2020;(141)1404-1418.

W, Shimizu. Arrhythmias originating from the right ventricular outflow tract: how to distinguish “malignant” from “benign”? Heart Rhythm. 2009(6)1507-11.

Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7(1): 865-9.

Hasdemir C, Ulucan C, Yavuzgil O, Yuksel A, Kartal Y, Simsek E, et al. Tachycardia induced cardiomyopathy in patients with idiopathic ventricular arrhythmias the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol. 2011. 22(1):663–668.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2017;138:272–391.

Kubac G, Klinke WP, Grace M. Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature. Heart Rhythm. 2012;9:1465-72.

Zhong L, Lee YH, Huang XM, Asirvatham SJ, Shen WK, Friedman PA. Relative efficacy of catheterablation vs antiarrhythmic drugs in treating premature ventricular contractions a single-center retrospective study., et al. Heart Rhythm. 2014;(11):187-193.

Stec S, Sikorska A, Zaborska B, Kryński T, Szymot J, Kułakowski P. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation. Kardiol Pol, 2012;(70):351–358.

Morganroth J, Goin JE. Quinidine-related mortality in the short-tomedium-term treatment of ventricular arrhythmias. Circulation. 1991;84:1977–83.

Waldo AL, Camm AJ, deRuyter H. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Lancet. 1996;348:7-12.

Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, et al. Management of asymptomatic arrhythmias: a European Heart RhythmAssociation (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm. Europace. 2019;10: 1-32.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


Gedung Kampus 1 Fakultas Kedokteran Universitas Muhammadiyah Sumatera Utara | UMSU

Lantai II,Laboratorium Farmakologi dan Terapi FK UMSU-Jalan Gedung Arca No. 53 Medan-Sumatera Utara ,

Kode Pos 20217 Kontak: 0812-6208-2844,E-mail:

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
View My Stats Buletin Farmatera